AquaBplus Water Purification System, Part Number 24-2000-0, AquaBplus 2500 - Typ USA (G02040108-U...
FDA Device Recall #Z-1364-2022 — Class II — August 3, 2021
Recall Summary
| Recall Number | Z-1364-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 3, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Holdings, Inc. |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | 2 units |
Product Description
AquaBplus Water Purification System, Part Number 24-2000-0, AquaBplus 2500 - Typ USA (G02040108-US), AquaBplus 2000 - Typ USA (G02040114-US), AquaBplus HF -Typ USA (G02040120FMC-US)
Reason for Recall
AquaBplus HF module on the AquaBplus 2000 osmosis system, an error in the US Installation Guideline instructed that 3-ring mains, instead of 2-ring mains, may be installed in combination with an AquaBplus 2000 device. The 3-ring main and fluid fly loops the heat disinfection may not be as effective as a 2-ring main installation
Distribution Pattern
US Nationwide distribution in the states of NC and WV.
Lot / Code Information
UDI-DI: (01)04251285200227, (01)04251285200289, (01)0425128520; Serial Numbers: 7BPS1621 7BDS0783 7BFS0517 7BPS1611 7BDS0776 7BFS0502
Other Recalls from Fresenius Medical Care Holdings, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0936-2026 | Class II | 5008X CAREsystem +CLiC +CDX; | Oct 25, 2025 |
| Z-0041-2026 | Class II | Optiflux¿ High Flux E-beam Dialyzer Model Numb... | Aug 29, 2025 |
| Z-1992-2025 | Class II | 5008X HDF Hemodialysis Blood Tubing Set, 24 uni... | Apr 29, 2025 |
| Z-0801-2025 | Class II | Dialyzer Optiflux 160NRe | Dec 5, 2024 |
| Z-3124-2024 | Class II | Blood Pressure Module BPM3 TM-2917B (Spare Part... | Aug 8, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.